Cell-based leather
-
DATABASE (856)
-
ARTICLES (601)
Part of the Thai-headquartered venture capitalist firm Ardent Capital, Ardent Ventures invests in early-stage technology startups across Southeast Asia. In 2016, Ardent Capital announced its merger with US-based Wavemaker Partners.
Part of the Thai-headquartered venture capitalist firm Ardent Capital, Ardent Ventures invests in early-stage technology startups across Southeast Asia. In 2016, Ardent Capital announced its merger with US-based Wavemaker Partners.
US-based Sovereign's Capital is a private equity and venture capital firm specializing in early growth-stage companies in emerging markets. The company typically invests between US$250,000 and US$2 million.
US-based Sovereign's Capital is a private equity and venture capital firm specializing in early growth-stage companies in emerging markets. The company typically invests between US$250,000 and US$2 million.
TreeFrog Therapeutics’ C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment that mimics the way cells grow in the human body.
TreeFrog Therapeutics’ C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment that mimics the way cells grow in the human body.
Tony Fadell is the inventor of the iPod, co-inventor of the iPhone, and former CEO and founder of Nest Labs, which was later acquired by Google. He is also an angel investor and head of Paris-based deeptech advisory and investing firm Future Shape, which has over 200 companies in its portfolio and a focus on issues like the electrification and digital connection of things, biomanufacturing and the eradication of waste. Fadell has invested in at least 10 startups, with his most recent disclosed investments having taken place in 4Q20. These included his participation in the $7m seed round of London-based consumer technology and conceptual design house Nothing, the $45m Series B round of US biotech firm and vegan leather maker MycoWorks, well as the $31m Series A round of video call effects and presentation tools company mmhmm.
Tony Fadell is the inventor of the iPod, co-inventor of the iPhone, and former CEO and founder of Nest Labs, which was later acquired by Google. He is also an angel investor and head of Paris-based deeptech advisory and investing firm Future Shape, which has over 200 companies in its portfolio and a focus on issues like the electrification and digital connection of things, biomanufacturing and the eradication of waste. Fadell has invested in at least 10 startups, with his most recent disclosed investments having taken place in 4Q20. These included his participation in the $7m seed round of London-based consumer technology and conceptual design house Nothing, the $45m Series B round of US biotech firm and vegan leather maker MycoWorks, well as the $31m Series A round of video call effects and presentation tools company mmhmm.
Founded in 2010, Merah Putih is Indonesia’s first startup incubator. The Jakarta-based incubator focuses on mobile, gaming, community base and e-commerce. Its investment portfolio includes Infokost.id, Dailysocial and LintasBerita. Merah Putih is a collaboration between MCM Group and GDP Venture.
Founded in 2010, Merah Putih is Indonesia’s first startup incubator. The Jakarta-based incubator focuses on mobile, gaming, community base and e-commerce. Its investment portfolio includes Infokost.id, Dailysocial and LintasBerita. Merah Putih is a collaboration between MCM Group and GDP Venture.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
Possibly Europe's most famous e-commerce investor, Rocket Internet is known for replicating the business models of successes like Amazon, Alibaba and Uber in new markets. Rocket is based in Berlin and was founded in 2007 by brothers Oliver, Alexander and Marc Samwer. It went public in 2014.
Possibly Europe's most famous e-commerce investor, Rocket Internet is known for replicating the business models of successes like Amazon, Alibaba and Uber in new markets. Rocket is based in Berlin and was founded in 2007 by brothers Oliver, Alexander and Marc Samwer. It went public in 2014.
Founded in Silicon Valley by serial investor and founder of Google Ventures Bill Marris, Section 32 has multiple investment interests with medicine and biotech key amongst them. Marris himself has invested in over 500 companies, with over one-third resulting in IPO or M&A. Fifty of his portfolio companies have exceeded $1bn valuations, including Uber. Section 32 currently has 48 companies in its portfolio. Its most recent investments have included in Canadian remote medicine platform Cover Health’s $43m Series B round and in the $100m Series B round of US cancer detection software C2i Genomics, both in April 2021. In March 2021, it participated in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Founded in Silicon Valley by serial investor and founder of Google Ventures Bill Marris, Section 32 has multiple investment interests with medicine and biotech key amongst them. Marris himself has invested in over 500 companies, with over one-third resulting in IPO or M&A. Fifty of his portfolio companies have exceeded $1bn valuations, including Uber. Section 32 currently has 48 companies in its portfolio. Its most recent investments have included in Canadian remote medicine platform Cover Health’s $43m Series B round and in the $100m Series B round of US cancer detection software C2i Genomics, both in April 2021. In March 2021, it participated in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Founded in September 2019 by Patrick Morris, Eat Beyond went public on the Canadian Securities Exchange in November 2020. The company’s shares are also traded on the Frankfurt Exchange in Germany and OTC Markets in the US. Morris had worked in capital markets for over 15 years and wanted to find a solution to help retail investors access the emerging markets of alt-proteins and other future food sectors.First of its kind in Canada, the Eat Beyond Global Investment Fund focuses on four key areas: meat, seafood, eggs, and dairy. It also participates in cell agriculture and other experimental projects. Current investments include foodtechs and alt-food source companies working on plant-based proteins, fermented proteins, cultured proteins, agriculture and consumer packaged goods.
Founded in September 2019 by Patrick Morris, Eat Beyond went public on the Canadian Securities Exchange in November 2020. The company’s shares are also traded on the Frankfurt Exchange in Germany and OTC Markets in the US. Morris had worked in capital markets for over 15 years and wanted to find a solution to help retail investors access the emerging markets of alt-proteins and other future food sectors.First of its kind in Canada, the Eat Beyond Global Investment Fund focuses on four key areas: meat, seafood, eggs, and dairy. It also participates in cell agriculture and other experimental projects. Current investments include foodtechs and alt-food source companies working on plant-based proteins, fermented proteins, cultured proteins, agriculture and consumer packaged goods.
EMTEK (PT. Elang Mahkota Teknologi Tbk.)
Founded in 1983, EMTEK is Indonesia’s second-largest media group.
Founded in 1983, EMTEK is Indonesia’s second-largest media group.
Since 2003, US-based Wavemaker Partners have invested in more than 150 technology startups. The firm usually start with a US$100,000–$750,000 check and can follow on until US$1 million to US$1.25 million. Its investment portfolio in Asia-Pacific includes Luxola and TradeGecko. In 2016, it acquired Ardent Capital’s VC portfolio, which includes Sale Stock and Happyfresh.
Since 2003, US-based Wavemaker Partners have invested in more than 150 technology startups. The firm usually start with a US$100,000–$750,000 check and can follow on until US$1 million to US$1.25 million. Its investment portfolio in Asia-Pacific includes Luxola and TradeGecko. In 2016, it acquired Ardent Capital’s VC portfolio, which includes Sale Stock and Happyfresh.
Lever VC was founded in 2018 by Nick Cooney, an early investor of Beyond Meat and Memphis Meats. He is also the co-founder of Good Food Institute. Lever has currently invested in 14 startups from the US, Europe, Asia and Latin America.Focused on investments in early-stage alternative protein companies, the firm announced the first close of its Lever VC Fund I in August 2020, with its fourth close at $46m in April 2021. The final close will be completed by June 2021. Investors in the fund include NFL and NBA athletes, British nobility, food businesses, alt-protein companies and family offices as limited partners.In June 2020, Lever launched a $28m joint investment fund and accelerator to invest in Chinese plant-based and cell-cultivated meat and dairy companies. The Lever China Alternative Protein Fund will invest RMB 40m in alt-protein companies in mainland China over the next four years.
Lever VC was founded in 2018 by Nick Cooney, an early investor of Beyond Meat and Memphis Meats. He is also the co-founder of Good Food Institute. Lever has currently invested in 14 startups from the US, Europe, Asia and Latin America.Focused on investments in early-stage alternative protein companies, the firm announced the first close of its Lever VC Fund I in August 2020, with its fourth close at $46m in April 2021. The final close will be completed by June 2021. Investors in the fund include NFL and NBA athletes, British nobility, food businesses, alt-protein companies and family offices as limited partners.In June 2020, Lever launched a $28m joint investment fund and accelerator to invest in Chinese plant-based and cell-cultivated meat and dairy companies. The Lever China Alternative Protein Fund will invest RMB 40m in alt-protein companies in mainland China over the next four years.
Founded in London in 2009, Parkwalk is a specialist investor in deeptech spin-offs created at UK universities. Parkwalk currently has over £375m of assets under management and has invested in over 100 companies to date, emanating from the universities in Oxford, Cambridge, Imperial and Bristol, becoming the UK’s most active VC outside London. It currently has 143 portfolio companies, Its recent investments include the $17m May 2021 Series A round of cell therapy medtech Mogrify and in the April 2021 £1.9m seed round of HexagonFab, a medtech producing analytical lab instruments.
Founded in London in 2009, Parkwalk is a specialist investor in deeptech spin-offs created at UK universities. Parkwalk currently has over £375m of assets under management and has invested in over 100 companies to date, emanating from the universities in Oxford, Cambridge, Imperial and Bristol, becoming the UK’s most active VC outside London. It currently has 143 portfolio companies, Its recent investments include the $17m May 2021 Series A round of cell therapy medtech Mogrify and in the April 2021 £1.9m seed round of HexagonFab, a medtech producing analytical lab instruments.
Future Positive Capital is a Paris-based VC with a second office in London. Its investments cover deep-technology companies applying AI, biotechnology, synthetic biology, as well as robotics. Co-funded in 2016 by ex-Index Ventures associate Sofia Hmich along with Alexandre Terrien and Michael Rosen; it has made 18 investments to date. In 2019 Future Positive raised over $57m pan-European impact investment fund, claiming that most European VCs are continuing to staying focused on sectors, such as consumer, fintech, and marketing, or web and mobile technologies. Future Positive’s belief is that there is instead, a long-tail of investment opportunities to back businesses that actually tackle “the world’s most pressing problems”.Through this fund, it will back throughout Seed and Series A stages, with the possibility to follow up on Series B investing between around €300,000 and €5m. Since then the company has backed startups in the like of BioBeats, an AI company focused on preventative mental health, cell-based startup Meatable, and more recently NotCo, the Chilean unicorn disrupting the food and beverage sector with AI-enabled plant-based products.The team counts on an extensive network of mentors, innovators, impact angel investors and entrepreneurs such as F1 pilots Nico Rosberg, the MD of Alibaba France Sebastien Badault, the Omid Ashtari the President of Citymapper amongst others.
Future Positive Capital is a Paris-based VC with a second office in London. Its investments cover deep-technology companies applying AI, biotechnology, synthetic biology, as well as robotics. Co-funded in 2016 by ex-Index Ventures associate Sofia Hmich along with Alexandre Terrien and Michael Rosen; it has made 18 investments to date. In 2019 Future Positive raised over $57m pan-European impact investment fund, claiming that most European VCs are continuing to staying focused on sectors, such as consumer, fintech, and marketing, or web and mobile technologies. Future Positive’s belief is that there is instead, a long-tail of investment opportunities to back businesses that actually tackle “the world’s most pressing problems”.Through this fund, it will back throughout Seed and Series A stages, with the possibility to follow up on Series B investing between around €300,000 and €5m. Since then the company has backed startups in the like of BioBeats, an AI company focused on preventative mental health, cell-based startup Meatable, and more recently NotCo, the Chilean unicorn disrupting the food and beverage sector with AI-enabled plant-based products.The team counts on an extensive network of mentors, innovators, impact angel investors and entrepreneurs such as F1 pilots Nico Rosberg, the MD of Alibaba France Sebastien Badault, the Omid Ashtari the President of Citymapper amongst others.
Qorium: Lab-grown premium leather for the future of luxury
The Dutch biotech startup co-founded by cell-based meat pioneer Mark Post is targeting the luxury goods market with its “clean leather” sheets made from cultivating bovine skin cells, and plans to raise up to €100m
Beyond Leather Materials: Turning apples into alt-leather for sustainable fashion
Through its Leap brand, the Danish startup cuts food waste by turning apples junked in cider factories into affordable vegan leather for the $100bn leather market
Eco-friendly vegan leather from recycled waste, made in Indonesia
In the battle for ethical consumer dollars, mass production of vegan leather by startups like Mycotech and Bell Society, could be the game-changer for the fashion industry
Biomilq: Creating cell-based mothers’ milk in a lab
With the aim of helping women struggling to breastfeed, Bill Gates-backed Biomilq is disrupting the $45bn baby formula industry developing lab-grown breast milk from mammary epithelial cells
Meatable: Cell-based meat startup secures $47m Series A for scalable technology
The Dutch startup offers a pioneering technology for quickly scaling cell-based meat production while eliminating the need for animal-derived growth media
Big Idea Ventures Founder Andrew D Ive: Asia will lead cell-based meat innovation
In a wide-ranging interview, the managing general partner of the US- and Singapore-based foodtech investor also expounds on his goal to extend sustainability to the rest of the food sector, combining good returns with doing good
Meatable joins Royal DSM to create growth media specific for cell-based meat tech
The R&D between the biotech startup and fellow Dutch nutrition conglomerate could help scale and drive the commercial viability of lab-grown meat
TreeFrog Therapeutics: Mimicking how stem cells grow in the human body
The French biotech’s proprietory technology to cultivate pluripotent stem cells in a 3D environment can be scaled to mass-produce high-quality cells to treat diseases such as Parkinson’s
TurtleTree Labs: Creating sustainable mammalian milk alternatives from stem cells
Founder’s search for high-quality dairy milk led to the creation in a lab of naturally occurring ingredients found in human milk for supply to dairy milk and infant formula businesses
Cubiq Foods: Bioreactor farms producing the food of tomorrow
Growing appetite for meat alternatives expected to fuel demand for Cubiq’s low calorie, Omega 3-enriched lab-grown fats
Cocuus: Industrial-scale solutions to design and print food
This Spanish startup is pioneering industrial-scale 3D food printing using inkjet and laser technology that prints up to 30 times faster with eye-catching food designs
Indonesian local crafts marketplace Qlapa shuts down
Series A funding failed to keep startup afloat as business remains unprofitable, regional heavyweights close in
Singapore, the place to start and grow a cellular agriculture startup
A country that imports over 90% of its food supply, Singapore has turned to foodtech, including cellular agriculture, to safeguard food security, supported by proactive regulators
iCell: Upcycling nutrients from wastewater
Hong Kong-based iCell Sustainable Nutrition makes single-cell proteins with wastewater from food and beverage factories, generating revenue and purifying the water for safe discharge or reuse
Because Animals: Pioneering cultured meat for pets
The biotech startup is disrupting the pet food processing industry with cell-based food to minimize environmental “pawprints” and promote animal welfare
Sorry, we couldn’t find any matches for“Cell-based leather”.
POPULAR DATABASE
